Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Taking vitamin D daily decreased cancer mortality, according to a study.

2.

Radiation therapy can promote amphiregulin, which increases growth of metastases

3.

Preoperative Embolization Linked to Relapse-Free Survival in Meningioma

4.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

5.

Improved end-of-life conversations for cancer patients are identified by a new study.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot